Latest News

Biosante Pharmacueticals, who are running phase III trials for the latest hopeful in HSDD (hypoactive sexual desire disorder), Libigel ( testosterone gel) have now completed the recruitment part of their trial and now may commence the study which will observe the safety and efficacy of this treatmen...

A London based man suffering from alopecia areata is selling his bald spot to companies as advertising space...

Researchers at the University of Warwick have uncovered a new type of cholesterol that has been proven to increase heart disease risk and the study is published in Diabetes...

According to the latest stats gathered by The Better Life Index, which compared 34 countries on a range of topics such as income, health, housing standards, education and crime, British people are fatter than other countries with similar economies...

In the latest Qnexa news, some exciting results have been published in the Journal of the American Medical Association which Vivus, Qnexa’s creators, hope will win them the approval of the FDA (Food and Drug Administration)...